Form 4 holding
10%+ Owner
Terns Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 529,762
- Estimated value
- $2,002,500
- Report date
- 23 Nov 2022
- Price
- $3.78
- Ownership
- Indirect
LAV Biosciences Fund V, L.P. - 10%+ Owner at Terns Pharmaceuticals, Inc.
Issuer-level insider activity
- Role
- 10%+ Owner
- Issuer ticker
- TERN
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by LAV Biosciences Fund V, L.P. since 13 Sep 2025
Reported holdings for LAV Biosciences Fund V, L.P. in Terns Pharmaceuticals, Inc.
Transaction history for LAV Biosciences Fund V, L.P. in Terns Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.